Stock·NASDAQ·Technology
Analog Devices, Inc. (ADI)
- Market cap
- $190.58B
- P/E
- 46.71
- Dividend yield
- 1.09%
- Street target
- $467.50median of 34 analysts
- 52-week range
- $224.25 $445.91
ADI stock forecast today
Where ADI stands today, and what CleaRank Financial AI makes of it.
ADI at a glance
Analog Devices, Inc. (ADI): Buy, 62/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($391.81 and $375.28).
- Earnings ADI beat estimates in 7 of the 7 reports in our data, yet fell in the first session after 3 of those beats.
- Insiders Insiders sold $126.6M and made no open-market purchases over the last 18 months.
- Valuation P/E of 46.7 against 35.1 for the Technology sector: a premium to peers (+33%).
Figures as of November 10, 2026.
CleaRank Financial AI
ADI (Analog Devices, Inc.) carries a CleaRank rating of Buy and a model score of 62/100.
The analysts' outlook does the most to lift that score, with 31 of 34 analysts rating the stock a buy and a median target 18.9% above the price. Valuation weighs on it most. The P/E of 46.71 is 33.1% above the sector median P/E (a premium to peers), and the P/S of 13.73 is 80.7% above the sector median P/S. The trend is up, with the price 0.38% above its 50-day average of $391.81 and 4.80% above its 200-day average of $375.28. Across the past year, the price climbed 69.53%.
Only on CleaRank
Figures we compute ourselves from ADI's own price, earnings and insider-filing history. Tap one to see it in context.
ADI stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $393.30 is 0.4% above the 50-day simple moving average of $391.81.Price above its 200-day average ›
The price is 4.8% above the 200-day simple moving average of $375.28.50-day average above the 200-day ›
The 50-day average ($391.81) is 4.4% above the 200-day average ($375.28), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 76% of its 52-week range, between $224.25 and $445.91.
ADI share price
Pick a period: each tab shows how far ADI has moved over it, to the last close.
Today's trading
Where ADI sits inside today's range and its 52-week range.
ADI fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E above the sector median ›
The trailing P/E of 46.71 is 33.1% above the Technology median of 35.1.P/S above the sector median ›
The price-to-sales ratio of 13.73 is 80.6% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $4.1B on revenue of $13.9B, a net margin of 29.8%.Beat estimates in most recent reports ›
ADI beat the EPS estimate in 7 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 1.09%, or $4.29 a share a year.
Key statistics
The headline figures for ADI.
As of November 10, 2026, ADI trades at $393.30, with a market value of $190.58B, a P/E ratio of 46.71 and a dividend yield of 1.09%.
What the numbers say
CleaRank Financial AI's reading of ADI's valuation, growth and risks.
On earnings, Analog Devices, Inc. (ADI) is valued at 46.71 times, against a median of 35.1 for Technology: a premium to peers, with the P/E 33.1% above that median. ADI trades at 13.73 times its sales, 80.7% above the sector median of 7.6. The company has a market capitalisation of $190.6B and trailing earnings of $8.42 a share.
Each dollar of sales turns into profit at a net margin of 29.79%, and the operating margin stands at 39.50%. Return on equity is 12.23%, which sits below the sector median of 13.4%. On the balance sheet, debt-to-equity is 0.27, and the trailing dividend yield of 1.09% works out to $4.29 a share per year.
Analog Devices, Inc. (ADI) reported $3.45 a share, which beat the $3.34 estimate for the August 19, 2026 report by 3.29%. The share price nonetheless slipped 0.89% in the first session after the report.
ADI has a clean earnings record, beating estimates in 7 of the 7 reports in our data. Even so, a beat has not always lifted the shares: the stock fell in the first session after 3 of those beats. Among the 3 reports before the latest, the biggest move followed the August 20, 2025 report, when EPS beat the estimate by 5.13% and the stock rose 6.26%. For this fiscal year, analysts average an EPS estimate of $12.88, growth of 65.3%, and they see $16.50 next year, up 28.1%.
Day-to-day volatility is the first thing to plan around: ADI has moved 3.39% on a typical session, and its beta against the S&P 500 is 1.26. The P/E of 46.71, 33.1% above the sector median, puts ADI at a premium to peers, so weaker results would meet a higher bar. Insiders sold $126.6M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
ADI against the Technology sector
How ADI compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: ADI trades at a significant premium to sector peers (+33% against the sector median P/E). Investors are paying more for each dollar of earnings than for the typical stock in the sector.
Return vs XLK: Since May 30, 2025, ADI has gained 83.8% against a gain of 46.3% for XLK.
Performance against XLK
ADI and the Technology sector fund over the same days.
Revenue and earnings
How much ADI sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to April 30, 2026); ADI reported again on August 19, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 16.9% in FY2025 to $11.0B, from $9.4B a year earlier.
Profit margin: The net margin was 20.6% in FY2025, up from 17.3% the year before.
Profitable: ADI earned $2.3B in FY2025.
Earnings reality check
Did ADI beat what analysts expected, and how did the stock react?
Earnings record: ADI beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 19, 2026before open | $3.34 | $3.45 | +3.29% | -0.89% | -0.79% |
| Feb 18, 2026before open | $2.31 | $2.46 | +6.49% | +2.63% | +5.51% |
| Nov 25, 2025before open | $2.23 | $2.26 | +1.35% | +5.27% | +14.02% |
| Aug 20, 2025before open | $1.95 | $2.05 | +5.13% | +6.26% | +10.93% |
| May 22, 2025before open | $1.70 | $1.85 | +8.82% | -4.63% | -2.91% |
| Feb 19, 2025before open | $1.54 | $1.63 | +5.84% | +9.74% | +6.85% |
| Nov 26, 2024before open | $1.64 | $1.67 | +1.83% | -2.03% | -0.91% |
As of November 10, 2026, ADI has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on August 19, 2026, came in 3.29% above the estimate and the stock moved -0.89% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
ADI AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 48.0, in neutral territory.RSI below 50 ›
An RSI of 48.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of ADI
The score, the reasoning behind it, and what could move the price next.
Analog Devices, Inc. (ADI) shows the layout of an uptrend, with the price above both of its long-run averages. At $393.30 the stock is 0.38% above its 50-day average of $391.81 and 4.80% above its 200-day average of $375.28. Within its 52-week range the price sits near the top, 11.80% below the high of $445.91 and 75.38% above the low of $224.25. The 50-day average is 4.40% above the 200-day, a gap that backs up the move instead of working against it.
A recent pullback sits inside a stronger longer record: the price fell 3.17% over the past month, rose 2.08% over the past three months and rose 69.53% over the past year. Volume in the last session ran 28.3% below its average, on a day the price fell 0.34%. The 14-day RSI of 48.0 is in the neutral zone, and the MACD line is negative.
New analyst coverage ›
BMO Capital started coverage at Outperform on August 21, 2026.
Source: Analyst action, BMO Capital, August 21, 2026Rating reaffirmed ›
TD Cowen kept its Buy rating on October 19, 2026.
Source: Analyst action, TD Cowen, October 19, 2026
Earnings beat, but the stock fell ›
The August 19, 2026 report beat the EPS estimate by 3.29%, and the share price fell 0.89% in the first session after it.
Source: Earnings report, August 19, 2026
- For Analog Devices, Inc. (ADI), the two levels to watch are the 20-day EMA at $399.21, just above the price, and the 50-day SMA at $391.81, just below it.
- The 14-day RSI reads 48.0, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- Analog Devices, Inc. (ADI) fell 0.89% in the first session after the August 19, 2026 report, even though it has beaten estimates in 7 of the 7 reports in our data.
The uptrend rests on ADI staying above its 50-day average at $391.81 and its 200-day average at $375.28; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 50-day SMA at $391.81.
For Analog Devices, Inc. (ADI), the nearest level overhead is the 20-day EMA at $399.21, which a rise would meet first.
Technical indicators
Momentum and trend for ADI, from its daily closes.
As of November 10, 2026, with ADI at $393.30, its 14-day RSI is 48.0 (neutral territory), its 50-day simple moving average is $391.81 and its 200-day is $375.28.
Calculated by CleaRank on daily closes as of November 10, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ADI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 10, 2026, ADI's 1-year correlation of daily returns is +0.70 with S&P 500 (SPY), +0.72 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.15 with gold (XAU).
ADI price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
31 of 34 analysts rate it a buy or strong buy, 3 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $467.50 is 18.9% above the price.Buy share not up from three months ago ›
31 of 34 rate it a buy now, against 31 of 34 three months ago.
ADI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | TD Cowen | Maintains | Buy |
| Sep 8, 2026 | TD Cowen | Reiterates | Buy |
| Aug 24, 2026 | Baird | Maintains | Outperform |
| Aug 21, 2026 | BMO Capital | Initiates | Outperform |
| Aug 20, 2026 | JP Morgan | Maintains | Overweight |
| Aug 20, 2026 | Morgan Stanley | Maintains | Overweight |
As of November 10, 2026, 34 Wall Street analysts cover ADI: 31 rate it a buy or strong buy, 3 a hold and 0 a sell or strong sell. Their 12-month price targets range from $365.00 to $675.00. The median ADI price target is $467.50, 18.9% above the price of $393.30.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ADI risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much ADI tends to move, against the market and on its own.
ADI price history and drawdowns
ADI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Typical daily move of 2% or more ›
A typical daily move is 3.39% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 30.7%, from January 2020 to March 2020, regained by June 2020.Most 1-year holds ended higher ›
88% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since December 2016 ›
$10,000 invested in December 2016 is now worth $68,115, against $39,967 in the S&P 500 (SPY).
ADI Drawdowns & Recovery
As of November 10, 2026, ADI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -30.7% (January 2020 to March 2020); it regained that peak by June 2020, 3 months after the low, and 88% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ADI in December 2016 is worth now, against the same amount in the S&P 500.
Against the market: ADI beat the S&P 500 over this period: $68,115 against $39,967.
A $10,000 investment in ADI in December 2016 would be worth about $68,115 today with dividends reinvested, compared with about $39,967 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ADI, and which have not.
Strongest month, November: an average of +8.03%, up in 7 of 9 years.
Weakest month, March: an average of -2.56%, up in 5 of 10 years.
This month, November: has averaged +8.03%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Across 10 calendar years of history, ADI's strongest calendar month has been November (average +8.03%, up in 7 of 9 years) and its weakest March (average -2.56%, up in 5 of 10 years).
Average return for each calendar month across 10 calendar years of history, from weekly closing prices with dividends included.
ADI stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ADI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in ADI today could grow to about $14,743 by 2030 in the base case, with a 90th-percentile outcome near $34,967 and a 10th-percentile outcome around $6,216. The simulation models price only; at today's 1.09% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ADI Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $580 for ADI by 2030 in the base case, from $393 today (1.5x over 4 years). The 10th-percentile path ends near $244. These are outcomes of a Monte Carlo simulation run on ADI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $281 | $433 | $667 | |
| 2028 | $259 | $478 | $879 | |
| 2029 | $249 | $526 | $1,112 | |
| 2030 | $244 | $580 | $1,375 |
Method: a lognormal simulation of ADI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
ADI insider trading
What the people running the company have bought and sold.
ADI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought ADI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 10, 2026, ADI insiders reported 52 open-market sales worth $126.6M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.3M |
| Nov 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Oct 20, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $584.2K |
| Oct 12, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 13.3K | - |
| Oct 7, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.2M |
| Oct 6, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $631.6K |
| Oct 2, 2026 | Vivek Jain
Chief Operating Officer
|
Sell | 2.0K | $834.0K |
| Oct 2, 2026 | Katsufumi Nakamura
Officer
|
Sell | 1.2K | $498.0K |
| Oct 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| Oct 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Sep 22, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $573.3K |
| Sep 18, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 19.2K | - |
| Sep 9, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.0M |
| Sep 8, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $545.5K |
| Sep 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.6M |
| Sep 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Aug 27, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $374.5K |
| Aug 26, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 2.7K | $1.0M |
| Aug 5, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.1M |
| Aug 3, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.6M |
| Aug 3, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Jul 13, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $389.8K |
| Jul 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.9M |
| Jul 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Jun 12, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $412.0K |
| Jun 9, 2026 | Raymond S Stata
Director
|
Sell | 1.4K | $574.0K |
| Jun 2, 2026 | Martin Cotter
Officer
|
Sell | 17.6K | $7.4M |
| Jun 2, 2026 | Martin Cotter
Officer
|
Option | 17.6K | $1.5M |
| Jun 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| Jun 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| May 26, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 60.0K | $24.4M |
| May 26, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 60.0K | $8.6M |
| May 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| May 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Apr 7, 2026 | Martin Cotter
Officer
|
Grant | 5.8K | - |
| Apr 7, 2026 | Vivek Jain
Officer
|
Grant | 6.7K | - |
| Apr 7, 2026 | Katsufumi Nakamura
Officer
|
Grant | 4.1K | - |
| Apr 7, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Grant | 6.5K | - |
| Apr 7, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 19.7K | - |
| Apr 7, 2026 | Michael Sondel
Officer
|
Grant | 1.3K | - |
| Apr 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.2M |
| Apr 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Mar 18, 2026 | Martin Cotter
Officer
|
Grant | 8.0K | - |
| Mar 18, 2026 | Vivek Jain
Officer
|
Grant | 12.6K | - |
| Mar 18, 2026 | Katsufumi Nakamura
Officer
|
Grant | 399 | - |
| Mar 18, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 55.9K | - |
| Mar 18, 2026 | Michael Sondel
Officer
|
Grant | 958 | - |
| Mar 11, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $2.0M |
| Mar 11, 2026 | Andre Andonian
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Edward H Frank
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Karen M. Golz
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Peter B Henry
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Stephen M Jennings
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Mercedes Johnson
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Yoky Matsuoka
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Raymond S Stata
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Andrea F Wainer
Director
|
Grant | 747 | - |
| Mar 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.5M |
| Mar 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Feb 25, 2026 | Michael Sondel
Officer
|
Sell | 4.2K | $1.5M |
| Feb 17, 2026 | Yoky Matsuoka
Director
|
Grant | 97 | - |
| Feb 5, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $2.0M |
| Feb 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.1M |
| Feb 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Jan 14, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $1.9M |
| Jan 9, 2026 | Katsufumi Nakamura
Officer
|
Sell | 500 | $150.7K |
| Jan 7, 2026 | Katsufumi Nakamura
Officer
|
Sell | 500 | $144.6K |
| Jan 5, 2026 | Martin Cotter
Officer
|
Sell | 10.0K | $2.8M |
| Jan 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.8M |
| Jan 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Dec 17, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.7M |
| Dec 17, 2025 | Martin Cotter
Officer
|
Sell | 5.0K | $1.4M |
| Dec 12, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.8M |
| Dec 12, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Dec 10, 2025 | Michael Sondel
Officer
|
Sell | 8.2K | $2.3M |
| Dec 10, 2025 | Michael Sondel
Officer
|
Option | 8.2K | $795.0K |
| Dec 9, 2025 | Martin Cotter
Officer
|
Grant | 1.6K | - |
| Dec 9, 2025 | Vivek Jain
Officer
|
Grant | 2.5K | - |
| Dec 9, 2025 | Katsufumi Nakamura
Officer
|
Grant | 135 | - |
| Dec 9, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 10.8K | - |
| Dec 9, 2025 | Michael Sondel
Officer
|
Grant | 203 | - |
| Dec 4, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 18.8K | - |
| Dec 1, 2025 | Vivek Jain
Officer
|
Sell | 5.9K | $1.6M |
| Nov 5, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Nov 3, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.3M |
| Nov 3, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Oct 7, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 11.3K | - |
| Oct 6, 2025 | Edward H Frank
Director
|
Sell | 1.0K | $242.7K |
| Oct 2, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Oct 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.4M |
| Oct 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Sep 18, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.6M |
| Sep 5, 2025 | Martin Cotter
Officer
|
Sell | 12.5K | $3.1M |
| Sep 2, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.5M |
| Sep 2, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Aug 27, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 20.0K | $5.1M |
| Aug 21, 2025 | Katsufumi Nakamura
Officer
|
Sell | 2.5K | $617.6K |
| Aug 21, 2025 | Katsufumi Nakamura
Officer
|
Option | 2.5K | $226.9K |
| Aug 6, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.4M |
| Jul 17, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Jun 12, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
Source: TwelveData, from SEC Form 4 filings
ADI stock forecast: questions people ask
Answered from the figures on this page, as of November 10, 2026.